Horák Petr, Underhill Jonathan, Batista Aida, Amann Steffen, Gibbons Nicholas
Hospital Pharmacy, University Hospital Motol, Prague 5, Czech Republic.
Centre for Medicines Optimisation, Keele University, Keele, UK.
Eur J Hosp Pharm. 2018 Sep;25(5):237-244. doi: 10.1136/ejhpharm-2018-001659. Epub 2018 Jul 31.
The 2017 EAHP European Statements Survey focussed on sections 2, 5 and 6 of the European Statements of Hospital Pharmacy. Statistical data on the level of implementation and on the main barriers to implementation of the Statements were collected. A further aim was to identify barriers in general, such as lack of awareness.
An online questionnaire was sent to all hospital pharmacies in European Association of Hospital Pharmacists (EAHP) member countries. Data were analysed at Keele University School of Pharmacy, UK by and the EAHP Survey Group.
There were 783 complete responses (response rate 17.4%). Some 42% of responders worked in teaching hospitals, 76% of hospital pharmacies had 10 or less pharmacists, and 46% of hospital pharmacies served over 500 beds.Five questions revealing the lowest implementation levels were further analysed in greater detail. Only 30% of respondents reported that their hospital pharmacists routinely publish hospital pharmacy practice research, and only 50% are involved in the development of local or national guidelines. 45% of respondents reported that computerised decision support was used to reduce the risk of medication errors in their hospitals, 69% stated that they had contingency plans for medicines shortages and 60% answered that they had had reason to contact their medicines authority because of drug shortages. 63% reported that the transcription step had been eliminated from the medicines administration process.
The survey has provided the EAHP with an overview of the implementation level as well as the barriers to and drivers of implementation of sections 2, 5 and 6. This is important for informing the plans of EAHP and its members so that implementation can be fully supported.
2017年欧洲医院药师协会(EAHP)欧洲声明调查聚焦于《欧洲医院药学声明》的第2、5和6部分。收集了关于声明实施水平及主要实施障碍的统计数据。另一个目标是总体识别障碍,如缺乏认识。
向EAHP成员国的所有医院药房发送了一份在线问卷。数据由英国基尔大学药学院和EAHP调查小组进行分析。
共收到783份完整回复(回复率17.4%)。约42%的回复者在教学医院工作,76%的医院药房药师人数为10名或更少,46%的医院药房服务床位超过500张。对显示实施水平最低的五个问题进行了更详细的分析。只有30%的受访者表示其医院药师定期发表医院药学实践研究,只有50%的人参与制定地方或国家指南。45%的受访者表示在其医院使用计算机化决策支持来降低用药错误风险,69%的人表示他们有药品短缺应急预案,60%的人回答他们曾因药品短缺而有理由联系药品管理部门。63%的人报告称药品给药流程中已取消转录环节。
该调查为EAHP提供了关于第2、5和6部分实施水平以及实施障碍和驱动因素的概述。这对于为EAHP及其成员的计划提供信息以便全面支持实施非常重要。